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Altheugh menstruation in the presence of an androgenic
adrenal carcinoma has been described,'6 there has been no
previous report of a successful pregnancy occurring in the
presence of an adrenal virilizing tumour. The difficulty in
conception and in maintenance of the pregnancy may have
been a manifestation of the excessive androgenic activity.
In spite of the virilization of' the mother the female child
showed no similar tendency. It has been shown that foetal
intersex of various types can be experimentally produced in
animals by the administration of androgens to the mother
during pregnancy.17 Similar effects may inadvertently be
produced in the human female by the administration of
androgens18.22 and progesterone,23.2. although masculinization
of the child is not invariable":'26 This latter observation has
been confirmed by the birth of a normal female in a case of
maternal arrhenoblastoma,27 as well as in our case of adrenal
tumour. However, the presence of maternal arrhenoblastoma
has resulted in masculinized infants in 2 recorded in-
. stances_28 ,29
SUMMARY
A case of adrenal virilizing tumour of many years' duration
is described in a young woman. Late in the course of the
disease she became pregnant imd gave birth to a normal
female infant. Subsequently the tumour underwent malignant
change and was removed, with dramatic regression of
symptoms and signs.
We wish to thank Prof. G. A. Elliott and Dr. S. Lopis for
their advice and criticism and Dr. W. M. Politzer for his help
with the steroid estimations.
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THE PASSAGE OF DRUGS ACROSS THE PLACENTA
N. SAPElKA, RA., M.D., PH.D., F.R.S.S.AF., Department ofPhysiology and Pharmacology, University of Cape Town
A large number of drugs are nowadays available for the
treatment of gynaecological, obstetrical and general medical
disorders, but relatively little is known with regard to the
transmission of therapeutic and toxic agents across the
placenta at various stages of gestation and at term. In recent
years an increasing amount of research on a scientific basis
has been devoted to estimations of the amounts of drugs
that reach the foetal blood and tissues and the amniotic
fluid; previously the irJformation was based almost entirely
on clinical observations of the foetus or the newborn. For
many drugs given during pregnancy or labour there is as
yet no available information regarding their passage across
the placenta and their effects on the foetus. Many statements
in the older literature are no longer valid in the light of modern
investigations. The whole subject is obviously of great
importance in the choice of a drug of therapeutic value to
the foetus, or for the avoidance of a drug that may be harmful
to the foetus. Drugs, poisons and other noxious substances
to which the mother was exposed before or during pregnancy
have in certain instances been the cause of foetal malforma-
-tions; e.g. the congenital malformations caused by rubella
virus.
Information on the placerltal transmission of drugs is
scattered in the literature, and a comprehensive account of
the available details is obviously very desirable. Consideration
has been given in the present article to the transfer of many
substances across the placenta and their direct effects on the
foetus; untoward effects on the mother have generally not
been mentioned, nor has consideration been given to drugs
which indirectly improve the prognosis for the foetus by
ameliorating the condition of the mother.
Methods of Investigation
Many methods of assay have been u ed to determine the
amount of drug that reaches the foetu after its administration
to the mother, including chemical, biological, microbiological,
and in recent years the use of radio-active isotopes. Details
are given in many of the investigations cited in this article.
In addition the following reports are mentioned for reference:
A method of collecting placental blood similar to that
employed in blood-donor centres is described by Siegel.173
In lItero investigation of the placental circulation, maternal
and foetal, by means of injections of saline, air and latex
is described by Earn and icholson. 53 McGaughey et al,135
have studied placental transfer and equilibration in normal
and toxic gestation by using antipyrine and sodium and
comparing blood samples from the umbilical vein and the
intervillous space (obtained by tran abdominal a piration).
The comparative physiology of placental transfer ba ed on
studies with radio-active odium is considered by Flexner
and Gellhorn.66 The ba ic structure of the human placenta
with a summary of previou ob ervations on placental
siructure i described by Hamilton and Boyd.89 The tructure
of the placenta of the full-time and immature foetu i
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described by Getzowa and Sadowsky75 and the structure of
placentas at various stages of gestation by Shanklin.172
Attention is al 0 drawn to studies on the histochemical
analysis of the human placenta described by Holzaepfel and
BarnesI03 and Wislocki and Dempsey.20l The exchange of
various molecules and ions across the isolated amniotic
membrane has been studied by Garby.72
Placental Function
The placenta is not and can seldom function as a semi-
permeable membrane. It appear at times to have a highly
elective action. It i an inces antly active 'barrier', and the
transfer of different kinds of substances depends upon the
cytological and cytochemical structures of the organ as well
as on simple diffu ion and filtration. With certain ex-
ceptions, substances of small molecular weight under 1,000
such a oxygen, carbon dioxide, and perhaps glucose, pass
through the placenta in either direction by simple diffusion,
and tend to as ume equal concentrations on both sides of
the placenta. Substances of higher molecular weight either
do not pass at all (e.g. ucrose) or are transferred in some
special way in which numerous enzymes appear to be con-
cerned.
Certain substances may also pass from the foet.us to the
mother (diaplacental passage), and Leinziger126 has
demon trated that contra t material may. pass from the
placenta into the maternal circulation (see also below re
foetal blood).
The constituents of the human foetus are derived from two
sources, viz. transplacental absorption from the maternal
circulation, and synthesis in -the foetal tissues.7s The
mechanisms of transfer include the following: I06
1. A pumping action of the placenta, serving as a foetal
pump or accessory foetal heqrt by virtue of its smooth
mu cle fibre, causing fluids to flow to and from the foetus;
2. A pumping action of the uterus pushing fluids towards
the decidual-placental junction, i.e. towards the foetal
circulation;
3. A biochemical enzymatic 'pumping' system, with
pos ibly adrenocortical hormones in the maternal circulation
playing a role. Then also the trophoblastic epithelium with
its cells and enzymes varying in function at various stages of
ge tation allows diffusion of certain substances and is higWy
selective in regard to others. A list of the enzymes of the
human placenta is given by Page. 35
A tentative classification of transport mechanisms across
the human placenta, based on the primary physiological
significance of the substance transferred, relative rates of
tran fer, and mechanisms of transport and distribution, has
been proposed by Page.147
The functional role of the placenta, transport, and the
eomparative anatomy and hi tology, were discussed at a
Conference on Gestation. 35
PHYSIOLOGICAL ASPECTS
The physiological function of tire placenta is to permit the exchange
of respiratory gases, nutrients, electrolytes, and water for foetal
growth. These substances and others must cross the barrier
consisting anatomically of 3 layers: trophoblastic epithelium,
chorionic connective tissue, and foetal endothelial capillary lining.
Fructose injected intravenously in women at the end of pregnancy
raises both foetal and maternal blood glucose, but intravenous
glucose raises the foetal fructose very little.
Calcium utilization by the foetus is influenced by the vitamin-D
intake of the mother, so that it is recommended that vitamin D
and calcium should be administered in normal pregnancy. The
developing foetus uses the dietary calcium of the mother about
5· I times more than the dietary strontium.3•
Fat appears to pass through the placenta to the foetal circulation.
PhospllOlipids marked with "P and injected into the circulation of
pregnant rabbits are taken up in large amounts by the placenta
but they are not transmitted to the foetus.'"
Amino acids injected into the mother increase the concentration
in the foetal blood, which is at all times slightly higher than that
of the mother. This is attributed to activity of the trophoblastic
epithelium rather than the foetus.'"6 There appears therefore to
be an active transport mechanism for amino acids across the
placenta. In healthy pregnant women at or near term it has been
found that both unnatural D-histidine and natural L-histidine
given intravenously cross the placenta by simple diffusion but the
natural isomer, which crosses more rapidly, is assisted by an
additional active transport mechanism.I"
Radio-active isotopes, e.g. radio-active inorganic salts, have been
used to study placental function and transmission, but need to be
applied with caution. Pohl and F1exnerI5' appear to have been the
first to explore this field of investigation.
Radio-sodium is exchanged rapidly and always in excess of the
metabolic demands of the foetus. It has been demonstrated that
the permeability of the human placenta increases with gestatIOn,
the rate for sodium at 36 weeks being 70 times that at 9weeks.65,1.'
These studies as well as the data on the transference of deuterium
oxide (heavy water)·7,m have made it seem likely that the
appearance time of radio-sodium in foetal blood is very short
and peak concentrations are reached very rapidly-within 2
minutes in human pregnancy at term.m The rate of transfer of
sodium per unit weight of placenta increases markedly as gestation
proceeds." The rate of passage of water and sodium from the
maternal ciTculation to the amniotic fluid indicates, that the water
of amniotic fluid is completely replaced, on average, every 2·9
hours, thus revealing that the amniotic fluid is not stagnant; the
rate of transfer of water is about 5 times more rapid than that of
sodium, -indicating that the water is renewed about 5 times as
rapidly as sodium.'·' It is of further interest that the exchange
of radio-sodium at the placental site continues unimpa"ired during
delivery until placental separation has taken place; thus, regardless
of the major alterations in the uterus which accompany its evacua-
tion at delivery, circulation in the intervillous spaces and exchange
across the placenta are maintained.
]n more recent studies it has been found by tracer methods
that the quantity of sodium transferred across the human placenta
is, on average, 450 times greater than is needed for the growth
increase of the foetus at the particular gestation period. 36
Radio-active sodium has been utilized for locating the placenta
in the intact human uterus, chiefly to determine whether maternal
blood can be obtained from the placenta in situ by aspiration."
Injection of radio-sodium into the mother has provided evidence
of the more insidious types of placental ischaemia.m The method
has also been used as a means of diagnosing foetal death. 31
Radio-iron studies (see also pharmacological section) have
shown that the accumulation of substances in the placental
parenchyma IS one of the features of foetal-maternal exchange.m
From studies with radio-active isotopes of iron and phosphorus
it was cautiously suggested that occasionally at the end of pregnancy
there may be leakage of substances or blood corpuscles across
the placenta from mother to foetus and vice versa.'" Criticism,
however, was made that such a placental lesion, when once it
occurs in cases where the male parent is homozygous Rh-positive,
should always recur in every subsequent pregnancy. Recently,
by the use of a new technique, which is not dependent on the blood
groups of the mother or foetus, it was demonstrated that the
transplacental passage of foetal blood to the mother's blood is
rather common.!o.
The ropper content of foetal liver is unusually high, but it
diminishes in the nursing period. The concentration in the liver
at birth is 4-10 times higher than in the mother. l6O The cerulo-
plasmin (copper-globulin) content of the serum of women is
elevated during the last trimester of normal pregnancy.so
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PHARMACOLOGICAL Th'VESTIGATIONS
DEPRESSANTS OF THE CENTRAL NERVOUS SYSTE 1
Alcohol passes through the placenta and can be found in the
foetal circulation. The toxicity of alcohol for foetal rats is about
the same as for adult rats. ""
Volatile anaesthetics easily pass the placental barrier and tend to
reach the same concentration in the foetal circulation as in the
maternal blood. With ether the concentration in the blood of
infants breathing immediately after birth is definitely less than
that of infants with neonataI apnoea, which suggests that ether
itself and not apnoea delays the onset of respiration.80 The passage
of ether into the foetus is rapid, and as anaesthesia progresses the
foetal concentrations approximate to those of the mother'"
in experiments on animals the concentration is almost the sa~e
in the brain and liver of the foetus as in the placenta, and much
lower than in the arterial blood and brain of the mother.
Cyclopropane, like ether, crosses the placenta almost quantitative-
ly. The average depression of infants receiving cyclopropane via
the mother is said to be significantly greater than with regional
or other inhalation anaesthesia.'
Nixtrolls oxide passes over very readily into the foetal blood
stream, where it is found in about 58 % of the concentration in
maternal blood." Administration to the mother of 90%-10%
nitrous oxide and oxygen promptly abolishes foetal respiratory
movement, while a mixture of 85-15 has no depressant effects
on the foetus for 40 minutes or longer.so
In addition to anaesthetic gases and vapours, the barbiturates,
paraldehyde, chloral hydrate, morphine, and pethidine are all
transferred from mother to foetus" Chloral hydrate, administered
orally in doses of 1.4 - 3· I g., is soon demonstrable not only in
the maternal but also in the foetal blood stream, and with no
ill-effects produced;'o large doses, however, may kill the foetus
in IIteroy3 After the administration of paraldehyde the concen-
tration in the foetal blood is about the same as in the mother's
blood.'" Tribromo-ethyl alcohol has been employed in the second
stage of labour, but depression of the foetal respiration sometimes
occurs and the drug is not advised in obstetrics.
Barbiturates
Barbiturates readily cross the placenta and are distributed
throughout the tissues of the foetus, so that doses for the mother
should not exceed an amount which will produce sedation during
labour. .Some obstetricians shun their use because they regard
them as l1able to depress the foetal respiratory centre like morphine,
but others have administered even large doses sufficient to produce
basal anaesthesia. Observation of the effect of a barbiturate on
the mother may give inadequate evidence of its effect on the child.
It is clear, however, that marked depression of the baby's respira-
tory centre can occur if large doses are given to keep a restless
mother quiet.
In experiments on cats, rabbits, and guinea-pigs with relatively
large doses of barbitone and amylobarbitone the concentration of
barbiturate in the foetus was found to be much higher than that
in the mother's brood, the uterus, the placenta and the amniotic
fluid'" Complete anaesthesia of pregnant cats with pentobarbitone
profoundly narcotizes the foetus so that most die within 2 hours.
Traces of barbiturate may be demonstrated in the amniotic fluid,
placenta and foetus of rabbits receiving hypnotic doses of barbitone
sodium." Foetal respiration is particularly sensitive to the thio-
barbiturates, as shown in rabbits, in which a dose that caused
50% decrease in the ventilation rate of the mother reduced the
foetal respiratory rate by 85 %, and this was not related to hypo-
oxia.50
Thiopentone has been found in minimal amounts in the blood
of the newborn infant up to 7 minutes after a single injection of
the barbiturate, and equilibrium between maternal and foetal
blood was reached within 10-12 minutes after the induction of
anaesthesia, after which the foetal level was very low." When this
thiobarbiturate was administered 4-11 minutes before delivery it
depressed the ability of the infant to gain normal adult oxygen
saturation; at the end of 1 hour the average saturation was 80%,
which was not significantly lower than in infants whose mother
received no general anaesthetic.l8· From estimations of the
maternal and placental concentrations of thiopentone it was found
that 58 % was transmitted across the placenta, with the foetal
concentration only reaching 28 % of the initial peak level attained
in the mother;33 the times of delivery of the infants in relation to
the injection of thiopentone are unfortunately not given by these
workers. Thiopentone given immediately before deli ery by
Mc~echnie and Converse'3' was found to cross the placenta
rapIdly, and in mixed umbilical-cord blood reached equilibrium
with the maternal venous blood in 3 minutes' it was unusual for
the babies to show respiratory d0pres ion. It' has been suggested
that thiopentone is di tributed from maternal blood to the maternal
ti sues 0 rapidly that the actual amount reaching the infant is not
enough to produce cerebral depres ion. On the other hand
Crawford" found that there was no appreciable placental barrier
to. thiopentone. Dundee5 ' states that there is a delay of at lea t 5
rrunutes III the maximum tran mi sion of barbiturate acro the
placenta; by the time equilibrium has been reached between
maternal and foetal blood levels the peak of concentration of
barbiturates in the mother will have pa sed.
Thioamytal injected intra enou ly in parturient women was
found to be in equilibrium in the maternal and foetal blood \ ithin
4-5 minutes, and thi equilibrium was maintained for at least 1
hour.m Pelltobarbitolle sodium cro es to the foetus almo t
immediately after intravenous injection in the mother, and reaches
74 % of the maternal blood level.·· Amylobarbitone and phello-
barbitone administered intramuscularly, and barbitone orally,
durmg the 4th to 7th months of human pregnancy, were demon-
strated by spectrophotometric methods to reach equilibrium in
maternal and foetal blood during the first 30 minutes, and the
rate of elimination was about the same in mother and foetus.'s,
The preparation l'illbarbital in doses of O· 3 g. caused delay in
respiration in the babies.'·<
More evidence is needed to support the view of certain workers
that different barbiturates vary in their effects on respiration.
In fatal human poisoning (suicide) the level .of barbiturate in
the foetal blood was almost twice as high as in the mother'
blood, O\ving to less effective detoxication and elimination.]"
Bromides given during pregnancy may produce eruptions on
the infant's face or body at birth (bromoderma).
Chlorpromazille given orally or intramuscularly for nausea and
v:omiting. and hyperemesis gravidarum in doses up to 50 mg. 3
tImes daily produced no harmful effects on mother or child· 17
also when given intramuscularly every 4-6 hours during labo~r,
alone or with analgesics and hypnotics, there were no significant
effects on the newborn.us When given with pethidine and hyoscine
in varying proportions to 1,881 patients delivered of 1,887 infant ,
active resuscitation was required in 2· 6%, there was moderate
respiratory depression in 11'9%, and 1'6% were stillborn"
'Trilafon' given together with tuinal, pethidine, and scopolamine,
or alone, in a double-blind study, produced no harmful effects in
the child."o
Reserpine appears to be transferred to the infant in utero'"
Rauwolfia (alseroxylon fraction), 1 mg. combined with amphe-
tamine sulphate 3 times daily, later twice daily, produced no
adverse effects on the foetus or the mother.'"
Analgesics
The peculiar sensitivity of the foetus to the depressant effect
of anal~esic drug is recognized and respiratory movements may
be abollshed ID the foetus at a level of analgesia which does not
impair maternal respiration.
Morphine readily crosses the placenta and is detectable in the
foetus both chemically and by its pharmacological effects. It has
caused death of the foetus in utero,113 and distinct tolerance is
found in the newborn of animals habituated to morphine.l61
Morphine has been in the main replaced by pethidine in normal
labour because of its depressant effect on the foetal respirator_
centre.
Dihydrocodeine given with hyoscine in repeated doses produced
analgesic effects comparable to those of pethidine with little
respiratory depression of the baby"·' One or more injections of
30 mg. subcutaneously, with one dose of 100-200 mg. of seconal
orally at the beginning, produced no depressant effect on the
foetus ill utero.]"
Pethidine has negligible effect on the respiratory centre of the
foetus unless large doses are administered late in the second stage
of labour. About 60-70% crosses the placenta. Less than 1 % of
a total dose of 100 or 200 mg. given during labour was found in
the uri~e .of the infants.m With doses that produce satisfactory
a.nal~esla ill the mother there is not necessarily significant depres-
sIOn I.D the newborn baby. The plasma concentration in the infant
may vary from 45 to 106% (average 77) of the levels measured
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simultaneously in the maternal blood.5 A mixture of 100 mg. of
pethidine, O· 3 mg. of hyoscine and 10 mg. of nalorphine given in
divided doses on demand by the patient for relief of pain during
labour (the maximum amount of pethidine given was 200 mg.)
caused no marked depression in the infants and none died.·'
Alphaprodine (nisentil), 40 mg. subcutaneously, does not produce
serious depression of the foetus, but when administered 5 times at
2-hourly intervals it produces foetal respiratory depression.88
Doses of 30 mg. or less given subcutaneously caused somewhat
less foetal depression than morphine and methadone.'" This
analgesic produces moderate or marked depression of the foetal
respiration, varying from 5 %117 to 16 %.156 0 foetal deaths have
been recorded.
Methadone produces depression of foetal respiration inter-
mediate in degree between that produced by morphine and by
pethidine. The subcutaneous injection of 10 mg. caused severe
foetal depression.'"
Levorphanol (dromoran) in analgesic doses depresses and delays
the respiration of the newborn infant.87
alorphine, injected about 10 minutes before delivery, or in
the newborn infant, has been used in the prevention and treatment
of neonatal depres ion due to analgesics used for sedation of the
mother. 55,56,'6,"
Salicylate readily crosses the placenta. In rabbits and rats it
passes into the foetal blood in the same concentration as that in
the maternal blood."o Abortion and foetal death occur only with
doses that are fatal to the mother.
OTHER DRUGS
Stimulants of the Central Nervous System
Caffeine administered in fairly large doses to dogs was found
in the foetal blood and liver in as high a concentration as in the
maternal tissues.6' StievelS5 a Berlin anatomist, found that when
small doses ofcaffeine were given to black rabbits during pregnancy
the offspring generally died and anatomical changes were
demonstrable in the placenta and in the offspring."3
Amiphenazole given intramuscularly to the mother in doses of
30 mg. reduces the depressant effect of morphine on foetal respira-
tion and reduces but does not completely eliminate neonatal
apnoea caused by morphine.,02
Autonomic Drugs
Amphetamine sulphate in 5 mg. doses combined with rauwolfia
(alseroxylon fraction) produced no adverse effect on the foetus
or the mother.'3
Hydergine given intravenously produced a small decrease in the
foetal heart rateY· Orally or sublingually it caused no foetal or
maternal complications. III
Hydralazine has not been shown to have any effects on the
infant.
eostigmine administered during pregnancy produced no ill-
effects on the foetus.·'
Atropine readily crosses the placenta and enters the foetal
circulation.
Ganglion-blocking Agents
These are best avoided during pregnancy because they can cross
the placenta and may cause paralysis of the intestine of infants.
Hexamethonium passes freely across the placenta in rabbits and
can soon be detected in the liquor. 208,207 The possibility ofaspiration
of amniotic fluid by the human foetus with harmful effects (ileus)
was suggested by Morris. '39 Large doses administered for
pregnancy toxaemia may cause ileus or bladder distension in the
infant; the bladder and stomach of the newborn should be emptied
since the amniotic fluid may have had a high concentration of
hexamethonium.'83 Submammary drip infusion given after an
intramuscular dose in severe toxaemia caused no apparent harm
to the foetus.'3
Mecamylamine appears to have caused fatal ileus in a premature
infant. 3 Because of this danger it is recommended that mecamyla-
mine should never be administered to pregnant women within
48 hours of the onset of labour. Repeated or big doses given to
the mother may produce effects on the foetal intestine that may
last for many days after birth.
Skeletal Muscle Relaxants
When quaternary ammonium muscle relaxants are present in
the maternal blood of animals the foetal blood does not contain
paralysing concentrations. Small amounts probably pass through
the rabbit placenta but the foetal neuromuscular junction is less
sensitive than that of the adult.·07
Tubocurarine does not appear to cross the placenta in significant
arnounts.1l6,40 Injection into the uterine artery of dogs near term
was followed by placental transmission of the drug in non-
dangerous amounts; in human babies delivered with the aid of
therapeutic doses of the relaxant, clinical curarization was not
observed.'50 Tubadil, a long-acting tubocurarine preparation,
given intramuscularly also produced no ill-effects on mother or
child. l98
Gallamine enters the foetal circulation more readily than tubo-
curarine. However, in a large series of forceps de.liveries and
Caesarian sections, 100 mg. caused no depression of the baby.m
It has been demonstrated in the foetal serum, often in readily
detectable and apparently significant amounts.40 In dogs it
crosses the placenta after injection into the uterine artery.'"'
Decamethonium crosses the placenta when given intravenously
in large doses just before delivery,·8 but did not do so when it was
injected into the uterine artery in dogs.'"'
Suxamethonium was found to cross the placenta by Little et aI.,m
but not so by Thesleff.'87 After injection into the uterine artery
in dogs it was found to pass through the placenta.'5'
Drugs Acting on the Cardiovascular System
Digitoxin, in radio-labelled form, and possibly its metabolic
products, were shown to pass through the placenta of rats and
guinea-pigs; on a tissue weight basis the concentration in the
foetal heart is higher than in the maternal heartY6 It would
appear that as the gestation period increases there is a correspond-
ing increase in the rate of transfer of digitoxin across the placenta.
Drugs Affecting the U.rine
Mersalyl does not pass into the amniotic fluidY·
Drugs Acting"on Blood Vessels
Ganglion-blocking agents, reserpine, hydralazine and other
drugs used in hypertension have already been considered.
Protoveratrine given orally or intravenously in toxaemia of
pregnancy produced no foetal death, no pooling of secretions in
the respiratory tree, and no respiratory depression."5
Antihistaminic Drugs
Promethazine (phenergan) given with pethidine to patients in
active labour had no apparent effect on the condition of the babie;;
at birth.· 3 •
Buclizine hydrochloride given in relaiively large doses over a
long period for nausea and vomiting of pregnancy was un-
associated with foetal, or maternal, complications.3•
The Respiratory System
Carbon dioxide 7· 5% in oxygen has little or no effect on foetal
respiration, in contrast to marked stimulation produced in the
mother.
Carbon monoxide was not found in the foetus in fatal poisoning
of a pregnant woman; the mother's blood was cherry-red in colour
but the blood of the foetus was dark in colour and contained no
carboxyhaemoglobin. These findings were adduced as an in-
dication that there is no transfer of red blood corpuscles across
the intact placenta, since CO is fixed in the red cells. l3• Caesarian
section might therefore be advisable to save a foetus near term.
However, in an analysis of the literature Curtis et al.'" found that
most authors have reported actual passage of CO from maternal
to foetal circulation, with several foetal deaths, but some authors
have stated that this does not occur. Recently Friberg et apo
demonstrated that CO is transmitted, slowly, from maternal to
foetal blood. In animal experiments it has been found that the
percentage saturation of foetal haemoglobin with CO depends
on the percentage saturation of the mother's haemoglobin and the
length of exposure to the gas.
Salts
Magnesium sulphate injected intravenously and intramuscularly
in toxaemia of pregnancy produced no signs of significant foeta!
depression although the degree of hypermagnesaemia in the foetus
closely paralleled that in the mother.150
Sodium fluoride passes freely across the placenta to the foetus''','·
but, while high concentrations in the mother mean high blood
levels in the baby, this is not in direct proportion. This has also
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been demonstrated in mice and, in the newborn mice, abnormalities
were observed in the jaw bones, enamel, and dental pulp.·' The
possibility that fluorine may cause mitotic disturbances and
teratism in the foetus is emphasized by Steyn.1S' Many workers
believe that the ingestion of fluoride by the mother during
pregnancy has no effect on the newborn child 'since it is only
available in small amount to the foetus, and some regard its
deliberate administration during pregnancy and lactation as
beneficial in reducing the incidence of caries in the child.
Drugs Acting on the Blood and Blood-forming Tissues
Cyanocobalamin crosses the placenta from mother to
foetus.sO,130,16. Attempts to influence foetal blood formation by
the administration of liver extract during pregnancy have not been
successful; this is not surprising since in pernicious anaemia the
administration of the haematinic principle in excess of the amount
necessary to produce a maximum response brings about no added
effect. Cyanocobalamin and folic acid in the mother's serum
decrease during pregnancy, owing presumably to their transfer
to the foetus.s In some cases the serum levels in the infant at
birth are more than 4 times as high as in the mother.
Iron is transferred from mother to foetus in considerable amounts
during pregnancy, 400 mg. to the foetus and 150 mg. t6 the
placenta, and large iron reserves protect the new born infant
against anaemia for a time if it is kept on a milk diet.los The
concentration of foetal serum iron at birth is almost double that
in the mother's serum. The transport of iron across the placenta
in rabbits has been studied by Bothwell et al.'l Potassium ferro-
cyanide or iron ammonium citrate injected into the mother does
not pass into the foetus, but with simultaneous administration of
ascorbic acid the ferric citrate is enabled to passYo Saccharated
iron oxide injected intravenously is rapidly transferred to the
foetus and converted into physiological iron compounds.m
Radio-active iron given orally in a single dose to pregnant
women near the end of gestation appears in the foetal circulation
within 40 minutes. It becomes widelv disseminated in the foetal
tissues, with the highest concentration in the red blood corpuscles
and the largest quantity in the liver. l" Red cells tagged with
radio-iron and injected into pregnant women produced significant
amounts of radio-activity in the blood of the foetuses in 25 out
of 29 patients.13s Other investigations with radio-iron are con-
sidered in the section dealing with physiological studies.
In women, red blood corpuscles have been shown to cross the
placenta from foetus to mother20' (see above); and sickle-trait
cells have been shown experimentally to cross the placenta to
the foetal circulation in a' small percentage of subjects.m
Dicoumarol has been given to women before, during and after
labour, with beneficial effect on phlebothrombosis, thrombo-
phlebitis, and pulmonary embolism; prothrombin estimations are
then absolutely essential. The anticoagulant crosses the placenta
and may'produce harmful effects on the foetus; cerebral haemor-
rhage may occur in the newborn infant. Intra-uterine death from
haemorrhage occurred in one foetus on the 53rd hospital day,
and it was delivered stillborn and macerated on the 74th day.l.'
In pregnant rabbits large doses caused death of the foetuses in
utero; although 'safe' prothrombin levels were maintained in the
mother the prothrombin activity was found to be markedly de-
creased in the infant rabbits at birth. 1%4
Drugs from Endocrine Glands
Oestrogens and androgens given in large doses to women in
early pregnancy appear to produce no adverse effect on the foetal
reproductive system." However, when large doses of oestrogens
are given to pregnant rats they produce feminized male offspring,S3
and androgens cause the production of mascuJinized female off-
spring.s,
Cortisone was, given by Wells'" for hyperemesis gravidarum
and 24 out of 27 infants were apparently normal at birth, but 3
had abnormalities (coarctation, club foot, undescended testes),
and another baby was later found to have cataract in one eye.
Katzenstein and Morrisll9 could find no evidence of damage to a
baby from cortisone and corticotrophin therapy given to the
mother. They also cite reports of other cases where steroid therapy
in pregnant women produced no damage in the babies. On the
other hand it has been demonstrated experimentally that cortisone
and corticotrophin may damage the foetus in lIlero in mice.7," ,77,182
and in rabbits.•7
Thyroid normone normally crosses the placenta and controls
the development of the foetal thyroid gland."
Thyroxine and tri-iodothyronine (labelled with l31n given by
injection have been studied in women with regard to their passage
from mother to foetus;14' the concentration of organic 1311 in the
foetal serum was approximately 1/IOth that in the maternal
serum. The passage of thyr'oxine across the placenta in guinea-pigs
and rabbits is ery slow. The rat placenta is slightly permeable to
thyroxine. lo'
Iodine administered during pregnancy for at least the last 4
weeks decreased the incidence of goitre in newborn infants in
Switzerland from 38% untreated to 8'4% treated.ool Hundreds of
thousands of pregnant women ha e taken about 100 !Lg. of
iodide every day without harmful effects on mother or ch.ild.S7
Studies with radio-active iodine have shown that in the human
foetal thyroid localization occurs at the time of appearance of
discrete thyroid follicles in the l4th-32nd weeks; concentration of
radio-iodine occurs only if the mother i injected after the thyroid
follicles develop." The human foetal thyroid can accumulate
demonstrable amounts of 1.11 by the 12th week of gestation.100
In a case treated with radio-iodine during the 6th month of preg-
nancy there was no detectable effect on the infant.""
Sodium radio-iodide (radio-active iodine) is considered to be
contra-indicated in pregnancy and lactation because it crosses the
placenta freely and is stored in the foetal thyroid after the 3rd
month. .
(Thiouracil compounds cross the placenta from mother to foetus
in animals,>'· leading to thyroid hyperplasia and cretinism in the
young; this has also occurred in human pregnancy."O,l40 This
drug-induced congenital goitre regresses progressively to normaLl
Thiouracil compounds can be used effectively for hyperthyroidism
in pregnancy, but the procedure is not without risk to the infant.)
Insulin apparently does not cross the human placenta, but in-
vestigations are still being made on this problem. The hormone
appears to pass across the placenta in the rat at full term, also in
rabbits and sheep.18' Alloxan, which h.as been much used experi-
mentally, is found within one or two minutes in the cord blood
of rats following its injection into the mother.7l
Vitamins
Ascorbic acid is always at a higher level in the foetal plasma
than in the maternal plasma. After administration of the vitamin
both the foetal and maternal plasma levels rise, followed by a fall,
which is slower in the foetal plasma. lo A detailed report on the
placental transfer of ascorbic acid in guinea-pigs and human
beings is given by Raiha.1S9
Riboflavine is also in higher concentration in human foetal
blood than in the maternal blood. The placenta probably effects
the transfer by taking flavin adenine nucleotide from the maternal
blood and splitting it to free riboflavine.m
Vitamin A and carotene in the foetus are both increased when
there is an increase in maternal carotene, but an increase in maternal
vitamin A is not followed by a similar response in the foetal
circulation,u It has been concluded that the principal transfer
to the foetus takes place in the form of carotene and the foetal
system converts the carotene to vitamin A. A period of several
weeks is required for these transplacental changes to occur.
Menaphthone crosses the placenta, and used prophylactically it
produces marked reduction in infant mortality and haemorrhages
(hypoprothrombinaemia of the newborn)."
Alpha-tocopherol concentration in the umbilical venous blood
is generally higher than in the maternal blood when the latter
tocopherol value is high, and 3-4 times higher than that of the
umbilical arterial blood.7 '
Metals
Copper (see above).
Mercurials cross the placenta. Congenital syphilis was at one
time treated by mercurial inunction of the mother, and the con-
centration in the amniotic fluid was found to be 0,2-0,6 mg.
per litreYs
_Lead administered to rabbits injured the chorionic epithelium
and caused coagulation necrosis and haemorrhages, with death
of the foetus." Rats are resistant to this effect. The quantity of
lead in the newborn animal (rats, dogs) is proportional to the
amount ingested by the mother.",141 The exposure of either
parent to lead is believed to decrease fertility, probably by inter-
fering with implantation or early development of the zygote.
/
;
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Lead-mining districts in Europe are stated to have an abnormally
high incidence of malformed and defective children.
Arsenic when given intravenously in the form of arsphenamine
and neoarsphenamine passes through the human placenta; traces
reach the foetus, not by simple diffusion but by some other
mechanism, and it is constantly present in the meconium of new-
born infants. 54 In rats, arsenic crosses the placenta when arsenic
trioxide is included in the diet.141
Bismuth passes freely across the placenta to be distributed in the
foetal tissues, including the bones. It has also been found in the
amniotic fluid of the human foetus." oa In rabbits the distribution
-in the tissues is the same as in the adult.127
LiThium salts exert a direct toxic effect on embryonic tissue, and
reduce the percentage of deliveries in pregnant mice. is
Selenium passes through the placenta of animals into the
foetus."· In stock poisoning the foetus may be born without
hoofs. The first evidence of the placental transmission of selenium
in human beings was recently reported.8•
Thallium passes into the foetus.·'
Boric acid (boron) passes through the rat placenta to the
foetus. l05
ChemOTherapeutic Agents
Sulphonamides readily pass through the placenta into the foetal
circulation and tissues. The blood levels are 50-90% of those in
the maternal blood. The drug appears more slowly in the amniotic
fluid than in the foetal blood. Sulphanilamide crosses freely,180
and so do sulphathiazole and sulphadiazine,182 and sulphamethoxy-
pyridazine}08
As regards toxic effects from sulphonamides the follo\ving reports
are cited. In rabbits sulphaniJamide was found to increase the
neonatal mortality' and large doses given to rats throughout
pregnancy also caused increased mortality.18I In pregnant mice
u1phadiazine and sulphamerazine decrease the number of
deliveries.J5 There is evidence of possible injury (anaemia and
jaundice) to the human foetus from sulphanilamide therapy,93
and acute liver atrophy and acute haemolytic anaemia resulted
from administration of sulphaniJamide to the mother.'· It has
been found that the administration of sulphonamides to rats
during the latter part of gestation produces almost complete
absence of calcification in the foetus; this is attributed to inhibition
of phosphatase.I' The continued administration of sulphaguanidine
to pregnant rats delays the development of the foetus.
There are rarely indications for prolonged administration of
sulphonamides during pregnancy. In view of the above findings
the continued administration of big doses may be hazardous.
Penicillin injected into the mother is transmitted through the
placenta, appearing in significant amounts in the foetal blood,
but usually much below that in the maternal blood; the antibiotic
is found also in the amniotic fluid. Bacteriostatic levels are reached
in the foetal circuJation."8, ',10','05,2' Thus adequate treatment in
pregnancy is almost lOO % effective in the prevention of congenital
syphilis or in curing an already infected foetus in utero. 198 ,I7l,41
Procaine penicillin and the penicillin ester penethamate hydriodide
given intramuscularly during labour cross the placenta and
satisfactory cord levels are maintained over a 24-hour periodY
STreptomycin passes through the placenta but the concentrations
found in the foetal blood and tissues and in the amniotic fluid are
50% or less of the concentration in the maternal plasma. I2O,8I,,.
Tefracyclines readily enter the foetal circulation in antibacterial
concentrations!' the levels usually being only ! -:l- of those in
the maternal blood. When oxytetracycline (2 g.) is administered
during labour some crosses the placenta and is present in cord
blood; it appears to have no harmful effects on the newborn."
In pregnant rats which ingested chlortetracycline the drug could
be demonstrated in foetal tissues.5'
Chloramphenicol is found in the foetal blood at a level about
:l- that in maternal blood. u8 After the administration of 2 g.
orally no toxic reactions occur in mother or infant, and the con-
centration in foetal cord blood is generally at a therapeutic
leveL"·',2'
Erythromycin crosses the placenta when a total multiple dose
ofO· 6 - 1·0 g. is administered within 18 hours of delivery.m
Quinine passes through the placenta and may cause congenital
blindness and deafness in the offspring from damage to the ganglion
cells of the retina or the internal ear. This view has been challenged.
It is strange that cases were not reported more frequently in
the past. Also to be considered is the fact that the effects of
rubella on the foetus have only been appreciated in recent years.
In malaria, quinine and more recently introduced compounds
have been used to prevent congenital infection which may occur
with P. jalciparum infection of the mother.
Mepacrine crosses the placenta.8o
Vaccines, Toxins, and Antitoxins
DiphTheria and pertussis and tetanus vaccines injected into
pregnant women produce a high titre of antibodies in more than
80% of the mothers and their infants;32 that is to say, trans-
placental protection against these diseases can be increased by
active immunization of the mother during pregnancy. Diphtheria
and tetanus antitoxins p'!ss the placenta and also the immune
bodies opposing the viruses of measles, smallpox, mumps, polio-
myelitis, and the ordinary upper respiratory infections.
Allergens and antigens, viral as well as others, may cross the
placenta. The transplacental passage of important allergens
rarely results in clinical manifestations of immediate postnatal
hypersensitivity and can seldom if ever be demonstrated by skin
tests at the time.85 The passage of the Rh antigen from foetus
to mother and the return of anti-Rh antibodies into the foetus
show that unchanged protein is able to cross the placenta. Im-
munization of an Rh-negative mother with Rh-positive blood
produces antibodies that enter the foetal circulation and destroy
the foetal cells, and similar phenomena may occur with other
antigens (e.g. in ABO incompatibility of the mother and foetus).
Glutinins (univalent antibodies) traverse the placenta more readily
than agglutinins (bivalent antibodies), as shown in studies on two
cases of erythroblastosis foetalis. 202
The transfer of antibodies from mother to· young before and
after birth has been studied in many laboratory animals and in
women. The transmission may be directly via the placenta or via
the amniotic fluid \vith selection of gamma globulins occurring at
the enterodermal lining of the foetal gut. The transfer of other
serum proteins from mother to foetus needs more study. The
selective placental transmission of whole homologous serum
proteins (albumin and gamma globulin) from mother to foetus
has been demonstrated in the near-term rhesus monkey; in this
animal the placenta resembles the human placenta very closely
in the later stages of pregnancy. The amniotic fluid appears to
play an unimportant role in the transfer of these proteins." The
placental transfer of albumin is reviewed by Winkler et al.!03
who also report on the placental passage of radio-active iodinated
rabbit albumin; this transfer is slow so that protein nutrition of the
foetus is dependent rather on the passage of simple amino acids
than the transfer of the larger protein fractions.
Drugs used in Neoplastic Diseases
NiTrogen mustard injected into pregnant mice in a single dose
at the IOth--l2th day of gestation had no aFlparent effect on the
mother but induced profound changes in the foetuses, some being
killed and others showing teratological anomalies."" In pregnant
rats nitrogen mustard has produced foetal abnormalities or foetal
resorption.92
Urethane has been administered "to a woman suffering from
chronic myeloid leukaemia; the baby showed no evidence of
leukaemia.10. In pregnant mice this drug may cause less young
to be produced per litter"o" and embryos may suffer malformations
or death.""
MercapTOpurine has been administered in acute leukaemia
complicating late pregnancy without producing ill effects in the
foetus.1.'
Folic acid antagonists, e.g. aminopterin and -methotrexate,
seriously interfere with embryogene~is through an action on the
embryonic mesenchyme. Decidual tissue and placental tissue
are unaffected by doses of the drugs which cause foetal death.
These drugs should not be administered during pregnancy.I'O
In the human subject 6-12 mg. of aminopterin administered in the
first trimester of pregnancy induced foetal death and spontaneous
delivery in 10 out of 12 cases. In young foetuses there was de-
pression of haemopoeiesis and necrosis of tissues; in 3 older
foetuses malformation of the cranium was present.188 In a recent
series of publications Thiersch"8' has reported on compounds
with anti-neoplastic properties which produce lethal effects on
rat foetuses in utero.
Sodium radio-iodine has been considered above in connection
with thyroid disorders. When 1311 was administered to a woman
with carcinoma of the thyroid the foetus delivered 6 days later
.,
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THE soum AFRICAN MEDICAL AND DENTAL COUNCIL: DIE SUID-AFRIKAANSE GENEE8-
KUNDIGE EN TANDHEELKUNDIGE RAAD
TO ALL MEDICAL PRACTITIONERS REGISTERED IN
THE UNION OF SOUTH AFRICA
AAN ALLE GENEESHERE GEREGISTREER IN DIE
UNIE VAN SUID-AFRIKA
I am instructed by the Council to direct the attention of all regis-
tered medical practitioners to the fact that the Council may take
cognizance of the following acts or omissions with a view to
disciplinary action under the provisions of Chapter IV of the
Medical, Dental and Pharmacy Act, Act o. 13 of 1928, as
amended:
(a) The acts or omissions prescribed in rule 25 of the rules
regarding conduct of which the Council may take cog-
nizance, viz.:
'(1) The performance by medical practioners, except
in emergency, of professional acts for the per-
formance of which they are inadequately trained
and/or insufficiently experienced.
(2) The performance under improper conditions and
surroundings of professional acts, except in
emergency.'
(b) The use of therapeutic measures (operative or non-
operative) for conditions for which such measures
cannot be reasonably justified.
In connection with (b) above, the Council desires to direct
the attention of practitioners to the fact that although this par-
ticular act is not specifically mentioned in the 'Rules regarding
conduct of which the Council may take cognizance: the Council
may nevertheless take cognizance thereof in terms of the pro-
visions of Section 47 of the Act, and if necessary take disciplinary
action.
BY ORDER OF THE COUNCIL.
Ek is opgedra deur die Raad om die aandag van alle geregis-
treerde geneeshere op die feit te vestig dat die Raad kennis mag
neem van die volgende handelinge of versuime met die oog op
dissiplinere stappe ingevolge die bepalings van Hoofstuk: IV van
die Wet op Geneeshere, Tandartse en Aptekers, Wet No. 13 van
1928, soos gewysig:
(a) Die handelinge of versuime voorgeskryf in reel 25 van
die reels betreffende gedrag waarvan die Raad kennis
kan neem, t.w.:
,(1) Die verrigting deur geneeshere van professionele
handelinge, behalwe in gevalle van noOO, waarin
hulle onvoldoende opleiding en/of ontoereikende
ondervinding het.
(2) Die verrigting van professionele handelinge onder
onbehoorlike omstandighede of in 'n onbehoorlike
omgewing, behalwe in geval van nood.'
(b) Die gebruikmaking van terapeutiese metOOes (operatief
of nie-operatief) vir·toestande waarvoor sodanige metOOes
nie redelikerwys geregverdig kan word nie.
In verband met (b) hierbo, vestig die Raad die aandag van
geneeshere daarop dat hoewel hierdie besondere handeling nie
spesifiek vermeld word in die ,Reels betreffende gedrag waarvan
die Raad kennis kan neem' nie, die Raad nogtans kennis daarvan
mag neem ingevolge die bepalings van Artikel 47 van die Wet,
en indien nodig dissiplinere stappe kan neem.










PASSING EVENTS: IN DIE VERBYGAAN
Disseminaled Sclerosis. A South African research worker is
anxious to trace all the known cases of disseminated sclerosis
in this country. In order to facilitate this survey all doctors who
know .of patients with this disease are requested to inform the
Editor, South African Medical Journal, P.O. Box 643, Cape Town,
and the information so obtained will be passed on to the investi-
gator conducting this survey. He will-then contact the informant
and ask for details about the patient... .. ..
Cape Midland Branch, General Practitioners' Revision Course.
The Cape Midland Branch of the Medical Association of South
Africa is sponsoring a week-end Revision Course for general
practitioners on 20 and 21 February 1960. Ward rounds and
lectures will be arranged by senior staff members of the local
hospitals, and Pro£. J. F. Brock:, Professor of Medicine, Uni-
versity of Cape Town, \vill be the guest lecturer and will also
take part in the seminars.
The number of practitioners which can be accepted for the
course is limited and applications for admission must be made to
the Hon. Secretary, Cape Midland Branch (M.A.S.A.), 69 Cape
Road, Port Elizabeth, as soon as possible... .. ..
Breathing Aid for Poliomyelitis Patients. A small type of vacuum
cleaner 20-inches long and very cheap, has been adapted into a
breathing aid for poliomyelitis patients. Known as the Dustette,
it is used in reverse to help polio victims to breathe. The machine
collects air and forces it into a plastic tube with a mouthpiece
on the end which the patient can hold between his teeth. If he
